Join to View Full Profile
indianapolisIndianapolis, IN 46240
Phone+1 317-492-9838
Fax+1 317-981-1937
Dr. Yang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Hongmei Yang is an internist in Carmel, IN and is affiliated with Indiana University Health University Hospital. She received her medical degree from Shanxi Medical University and has been in practice 24 years. She is experienced in hypertension, diabetes mellitus, botox injection, dermal fillers, and depression.
Education & Training
Indiana University School of Medicine/Ball MemorialResidency, Internal Medicine, 2009 - 2012
Shanxi Medical UniversityClass of 1993
Certifications & Licensure
IN State Medical License 2012 - 2025
IL State Medical License 2012 - 2014
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 20 citationsCD49a Identifies Polyfunctional Memory CD8 T Cell Subsets that Persist in the Lungs After Influenza Infection.Emma C. Reilly, Mike Sportiello, Kris Lambert Emo, Andrea M Amitrano, Rakshanda Jha
Frontiers in Immunology. 2021-09-09 - Risk of adverse pathological features for intermediate risk prostate cancer: Clinical implications for definitive radiation therapy.Hong Zhang, C.W. Doucette, Hongmei Yang, Sanjukta Bandyopadhyay, Craig E Grossman
Plos One. 2021-07-15 - 8 citationsDifferences in influenza-specific CD4 T cell mediated immunity following acute infection versus inactivated vaccination in childrenIan Shannon, Chantelle L. White, Hongmei Yang, Jennifer L. Nayak
The Journal of Infectious Diseases. 2021-06-15
Press Mentions
NNT‐Induced Tumor Cell “Slimming” Reverses the Pro‐Carcinogenesis Effect of HIF2a in TumorsJanuary 12th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
